Live by the EpiPen, die by the EpiPen
Zach Shallbetter

To be very clear — it’s a medical device patent, not a pharmaceutical patent, at issue here. If one is going to be encouraging legislative fixes, one should make sure that they actually address the problem at hand.

Show your support

Clapping shows how much you appreciated Charles Duffy’s story.